Incyte
Press Releases
Contact
Investor Relations

Webcast ImageWebcast
Incyte Corporation at Cowen and Company Healthcare Conference (Replay)
03/08/10 at 3:15 p.m. ET
Incyte Corporation at Cowen and Company Healthcare Conference
Monday, March 8, 2010 3:15 p.m. ET  
Webcast PresentationHelp Help
Listen to the Webcast in Windows Media Player Click here for webcast
Listen to the Webcast in Real Player Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
INCY (Common)
Exchange   NASDAQ Change   - 0.17 (1.35%)
Price   $12.42 Volume  3,493,374
Last Trade   March 10, 2010 | 4:00 p.m. ET

Corporate Profile

Incyte's vision is to become a leading drug discovery and development company by building a proprietary product pipeline of novel small molecule drugs. We have an experienced team with prior success in bringing important new drugs to market. We believe we have the resources, experience and drive to improve the lives of patients and build sustainable value for our shareholders.

Recent NewsMore >>


DateTitle 
February 25, 2010Incyte to Present at the Cowen and Company 30th Annual Health Care Conference
WILMINGTON, Del., Feb 25, 2010 (BUSINESS WIRE) -- Incyte Corporation (Nasdaq:INCY) announced today it will present at the Cowen and Company 30th Annual Health Care Conference on Monday, March 8, 2010 at 3:15 p.m. ET. Presenting for Incyte Corporation will be Paul Friedman, M.D., president and chief executive officer. The presentation will be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts. A replay of the p... 
Printer Friendly Version
February 18, 2010Incyte Reports 2009 Financial Results; Strengthens Balance Sheet; Provides 2010 Financial Guidance
Two Major Strategic Collaborations EstablishedStrong Year-End Cash Position with 2011 Debt RestructuredSubstantial Clinical Progress AchievedConference Call Scheduled Today at 8:30 a.m. ETWILMINGTON, Del., Feb 18, 2010 (BUSINESS WIRE) -- Incyte Corporation (Nasdaq:INCY) today reported fourth quarter and full year 2009 financial results, provided an update on key fourth quarter accomplishments and 2010 objectives, and announced its 2010 financial guidance. Paul A. Friedma... 
Printer Friendly Version
February 09, 2010Incyte to Report 2009 Financial Results and 2010 Financial Guidance and Provide Update on Drug Discovery & Development Programs on February 18
WILMINGTON, Del., Feb 09, 2010 (BUSINESS WIRE) -- Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its fourth quarter and year-end 2009 financial results conference call for 8:30 a.m. ET on Thursday, February 18, 2010. The schedules for the press release and conference call are as follows: Q4 & YE 2009 Press Release: ... 
Printer Friendly Version

Featured Reports


Download the Incyte 2008 Shareholder Letter (87.7KB PDF).

Click here to view our 10-K.


Notice To Readers: Incyte's press releases, presentations and printed remarks are included on this Web site for historical purposes only. The information contained in these documents and webcasts should be considered accurate only as of the date of the relevant document or presentation. This information may change over time; therefore, visitors to this Web site should not assume that the information contained in these documents or presentations remains accurate at a later time. We do not have any current intention, and expressly disclaim any obligation, to supplement, update or revise any of the information in these documents or presentations.


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

















Investor Tool Kit
Print PagePrint Page
E-mail PageE-mail Page
RSS FeedsRSS Feeds
E-mail AlertsE-mail Alerts
Financial Tear SheetFinancial Tear Sheet
Investor Contact
Pamela M. Murphy
VP, Investor Relations and Corporate Communications
Experimental Station
Route 141 & Henry Clay Road
Building E336
Wilmington, DE 19880
302.498.6944
302.425.2707
pmurphy@incyte.com

©Copyright 2008 Incyte Corporation Incyte